Neuman John 4
4 · SeaStar Medical Holding Corp · Filed Feb 27, 2025
Insider Transaction Report
Form 4
Neuman John
Director
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-06-14$3.69/sh+10,000$36,905→ 10,000 total - Purchase
Common Stock, par value $0.0001 per share
2024-06-17$4.35/sh+10,000$43,521→ 20,000 total - Purchase
Common Stock, par value $0.0001 per share
2024-08-15$5.24/sh+10,000$52,396→ 30,000 total - Purchase
Common Stock, par value $0.0001 per share
2024-12-11$2.04/sh+10,000$20,405→ 40,000 total
Footnotes (4)
- [F1]1. The price reported in Column 4 is a weighted average price of $3.6905. These shares were purchased in multiple transactions at prices ranging from $3.67 to $3.71, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]2. The price reported in Column 4 is a weighted average price of $4.3521. These shares were purchased in multiple transactions at prices ranging from $4.29 to $4.37, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]3. The price reported in Column 4 is a weighted average price of $5.2396. These shares were purchased in multiple transactions at prices ranging from $5.19 to $5.24, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F4]4. The price reported in Column 4 is a weighted average price of $2.0405. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.06, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.